标签：#health

She opposes abortion, is wary of peptides, supports limiting vaccines, vexes MAHA.

It's the data, stupid.

For a healthtech verification link, the usual SendGrid vs Resend vs Postmark debate starts too late: the best alternative transactional email API is the one that leaves reviewable evidence after delivery. Short answer: choose a transactional email API only after a small evaluation proves API sending, controlled templates, verified-domain operation, suppression handling, and retrievable delivery records; Infrai is a practical option when those basics matter more than SMTP migration or webhook-driven automation, while teams that require either of those should keep a provider that supplies them. That result sounds less exciting than a feature matrix. Good. A verification message is part of an account-control path, so the useful output of a provider experiment isn't a polished welcome email. It's an evidence packet that connects one signup, one approved template revision, one domain configuration, one send request, and one later delivery record without placing health data in the message or logs. My first pass at this decision would be deliberately small: one synthetic recipient, one expiring link, one correlation ID, and no production data. I don't promote the notebook experiment until the evidence can be checked mechanically. The catch is that a provider can pass the send test while failing the operating model because an auditor cannot reconstruct what happened later. Reliability begins with five linked artifacts Start with five claims and demand an artifact for each. The API accepted a send. The rendered body came from the approved template revision. The sending domain was verified and DKIM could be rotated. A suppressed recipient wasn't treated as a normal send. Finally, a delivery record could be pulled into the team's own evidence store. Google also expects senders to authenticate mail, so domain work is part of the experiment rather than a launch-week chore. For a reviewer, those records need to form one understandable chain: the synthetic signup created a correla

US healthcare is broken. Under RFK Jr., the research agency working to fix it is, too.

Save $250 off the Garmin Fenix 8, plus discounts on other popular fitness trackers from the brand.

At what point did you start to think you were an engineer? An engineer. What a lofty,...

The scanning and bloodwork health startup founded by Spotify's founder will officially launch in New York in about a month.

Research shows heat amplifies the dangers of pesticides.

Struggling with burnout? Procrastination? Reaching your goals? Let me share a few methods that help...

Again, the CDC did not publish a full report and instead simply put the data online.

Researchers found that a metabolite produced by gut bacteria can weaken the barrier that protects the brain and promote changes associated with the cognitive disease.

A new Apple documentary explores the life of Aziz “Zyzz” Shavershian, who rocketed to internet fame in an age before influencers, then died at age 22 in 2011.

We’ve been testing bands since the first Apple Watch launched in 2015. From silicone sports straps to leather bands, I’ve rounded up the best for every occasion.

Senator Warren questions whether Taylor Farms' influence swayed Trump admin.

This week I spoke to scientists who have found a way to turn male mouse embryos female. They’ve developed a CRISPR-based approach to essentially cut out the Y chromosome. It allowed them to create female clones of male mice. That’s right: female animals that are genetically identical to males, except for the missing Y chromosome.…

In 2017, Deanne Taylor attended a presentation at the University of Pennsylvania, just a short walk from her office. A researcher was there to unveil the Human Cell Atlas, an ambitious project that aimed to map every cell in the human body. Taylor was floored, and then concerned. As details emerged, she discovered that the…

Study finds wait times for cancer surgeries hit 10-year high.

The plaintiffs say they invested nearly $1.2 million in the company, and are accusing Gomez of failing to build and market the startup.

Over a billion people worldwide have livers with excess fat, which can lead to a host of medical problems. Researchers think AI tools can spot the condition—and help stop it—early enough to save lives.

Boy's unusual symptoms could help identify the next case sooner.